355 related articles for article (PubMed ID: 19217304)
1. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors.
Ottanà R; Maccari R; Ciurleo R; Paoli P; Jacomelli M; Manao G; Camici G; Laggner C; Langer T
Bioorg Med Chem; 2009 Mar; 17(5):1928-37. PubMed ID: 19217304
[TBL] [Abstract][Full Text] [Related]
2. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
[TBL] [Abstract][Full Text] [Related]
3. New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Amuso S; Wolber G; Schuster D; Herdlinger S; Manao G; Camici G; Paoli P
Eur J Med Chem; 2012 Apr; 50():332-43. PubMed ID: 22381357
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
[TBL] [Abstract][Full Text] [Related]
6. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.
Maccari R; Paoli P; Ottanà R; Jacomelli M; Ciurleo R; Manao G; Steindl T; Langer T; Vigorita MG; Camici G
Bioorg Med Chem; 2007 Aug; 15(15):5137-49. PubMed ID: 17543532
[TBL] [Abstract][Full Text] [Related]
7. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
9. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
Drake PG; Peters GH; Andersen HS; Hendriks W; Møller NP
Biochem J; 2003 Jul; 373(Pt 2):393-401. PubMed ID: 12697028
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
11. Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
Wan ZK; Lee J; Xu W; Erbe DV; Joseph-McCarthy D; Follows BC; Zhang YL
Bioorg Med Chem Lett; 2006 Sep; 16(18):4941-5. PubMed ID: 16806920
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL
Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216
[TBL] [Abstract][Full Text] [Related]
13. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
Schmidt MF; Groves MR; Rademann J
Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
[TBL] [Abstract][Full Text] [Related]
15. Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design.
Burke TR; Ye B; Yan X; Wang S; Jia Z; Chen L; Zhang ZY; Barford D
Biochemistry; 1996 Dec; 35(50):15989-96. PubMed ID: 8973169
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
[TBL] [Abstract][Full Text] [Related]
17. Novel thiophene derivatives as PTP1B inhibitors with selectivity and cellular activity.
Ye D; Zhang Y; Wang F; Zheng M; Zhang X; Luo X; Shen X; Jiang H; Liu H
Bioorg Med Chem; 2010 Mar; 18(5):1773-82. PubMed ID: 20153651
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
[TBL] [Abstract][Full Text] [Related]
19. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
[TBL] [Abstract][Full Text] [Related]
20. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies.
Shim YS; Kim KC; Lee KA; Shrestha S; Lee KH; Kim CK; Cho H
Bioorg Med Chem; 2005 Feb; 13(4):1325-32. PubMed ID: 15670940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
